SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kosan BioSciences -- KOSN -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (856)12/10/2007 1:19:44 PM
From: Icebrg  Read Replies (1) | Respond to of 933
 
-31% seems excessive. Anyone hear anything else?

Yes resp. "it seems so". I can't really figure out what went wrong here. The company has a relatively "broad" portfolio of drugs and indications.

These type of falls have however a tendency to feed themselves.

The sales volume is not at all excessive. Now standing at around 600.000 shares corresponding to say 2,4 mUSD. The total number of outstanding shares is 42,6 million.

Erik



To: keokalani'nui who wrote (856)12/10/2007 2:36:49 PM
From: mopgcw  Respond to of 933
 
I reloaded another slug to trade here. I think it is a broad portfolio and volatility to take some profits on over time.
good luck,

take care
george


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News